$18.68
2.45% yesterday
NYSE, Nov 15, 10:10 pm CET
ISIN
US05350V1061
Symbol
AVNS

Avanos Medical, Inc. Stock price

$18.68
-4.12 18.07% 1M
-1.35 6.74% 6M
-3.75 16.72% YTD
-2.76 12.87% 1Y
-14.89 44.36% 3Y
-13.64 42.20% 5Y
-19.08 50.53% 10Y
NYSE, Closing price Fri, Nov 15 2024
-0.47 2.45%
ISIN
US05350V1061
Symbol
AVNS
Sector

Key metrics

Market capitalization $858.48m
Enterprise Value $971.68m
P/E (TTM) P/E ratio 55.38
EV/FCF (TTM) EV/FCF 26.55
EV/Sales (TTM) EV/Sales 1.43
P/S ratio (TTM) P/S ratio 1.26
P/B ratio (TTM) P/B ratio 0.70
Revenue growth (TTM) Revenue growth -9.12%
Revenue (TTM) Revenue $681.50m
EBIT (operating result TTM) EBIT $62.40m
Free Cash Flow (TTM) Free Cash Flow $36.60m
Cash position $89.00m
EPS (TTM) EPS $0.34
P/E forward 212.78
P/S forward 1.28
EV/Sales forward 1.45
Short interest 1.89%
Show more

Is Avanos Medical, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.

Avanos Medical, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

3 Analysts have issued a Avanos Medical, Inc. forecast:

1x Buy
33%
2x Hold
67%

Analyst Opinions

3 Analysts have issued a Avanos Medical, Inc. forecast:

Buy
33%
Hold
67%

Financial data from Avanos Medical, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
682 682
9% 9%
100%
- Direct Costs 303 303
10% 10%
44%
378 378
9% 9%
56%
- Selling and Administrative Expenses 243 243
7% 7%
36%
- Research and Development Expense 27 27
4% 4%
4%
108 108
13% 13%
16%
- Depreciation and Amortization 46 46
2% 2%
7%
EBIT (Operating Income) EBIT 62 62
20% 20%
9%
Net Profit 16 16
128% 128%
2%

In millions USD.

Don't miss a Thing! We will send you all news about Avanos Medical, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Avanos Medical, Inc. Stock News

Neutral
PRNewsWire
3 days ago
ALPHARETTA, Ga. , Nov. 12, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, interim chief executive officer, will participate in an analyst-led fireside chat at the Stifel 2024 Healthcare Conference at the Lotte New York Palace in New York on Tuesday, Nov. 19 at approximately 3:35 p.m.
Neutral
PRNewsWire
4 days ago
ALPHARETTA, Ga. , Nov. 11, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) announced today that the Centers for Medicare and Medicaid Services (CMS) has issued its final Medicare Hospital Outpatient Prospective Payment System (OPPS) and Medicare Ambulatory Surgical Center (ASC) Payment System rule for 2025.
Neutral
PRNewsWire
7 days ago
ALPHARETTA, Ga. , Nov. 8, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, interim chief executive officer, will participate in a fireside chat at the UBS 2024 Healthcare Conference on Tues.
More Avanos Medical, Inc. News

Company Profile

Avanos Medical, Inc. is a medical technology company, which focuses on delivering clinically medical device solutions to improve patients' quality of life. Its portfolio of innovative product offerings focused on respiratory and digestive health, along with surgical and interventional pain management to improve patient outcomes and reduce the cost of care. Its brands include ON-Q, Coolife, Microcuff, MIC-Key, Quilbloc and Home pump. The company was founded on February 25, 2014 and is headquartered in Alpharetta, GA.

Head office United States
CEO Michael Greiner
Employees 3,771
Founded 2014
Website www.avanos.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today